Literature DB >> 5677419

Relationship of monoamine metabolites in human cerebrospinal fluid to age.

M B Bowers, F A Gerbode.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5677419     DOI: 10.1038/2191256a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Effect of caffeine on sleep: EEG study in late middle age people.

Authors:  V Březinová
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

2.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

Authors:  S N Young; S Lal; T L Sourkes; F Feldmuller; A Aronoff; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

4.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

Authors:  R Sjöström; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

5.  Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.

Authors:  D M Vaughn; G B Smyth; W L Whitmer; C Satjawatcharaphong
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

6.  Effect of aging on dopamine metabolism in the rat cerebral cortex: a regional analysis.

Authors:  F Godefroy; M H Bassant; Y Lamour; J Weil-Fugazza
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors:  G A Ricaurte; U D McCann
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

8.  Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.

Authors:  G Bucht; R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

10.  Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.

Authors:  S N Young; S Gauthier; G M Anderson; W C Purdy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.